Prophylactic antibiotic therapy for preventing poststroke infection

Infections, in particular pneumonia, are common complications in patients with acute stroke and are associated with a less favorable neurologic and functional outcome. Patients with severe stroke and dysphagia are at highest risk of infection. Experimental and clinical data suggest stroke-induced im...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: Schwarz, Stefan (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 August 2016
In: Neurotherapeutics
Year: 2016, Jahrgang: 13, Heft: 4, Pages: 783-790
ISSN:1878-7479
DOI:10.1007/s13311-016-0466-y
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/s13311-016-0466-y
Volltext
Verfasserangaben:Stefan Schwarz

MARC

LEADER 00000caa a2200000 c 4500
001 1669347095
003 DE-627
005 20230428192306.0
007 cr uuu---uuuuu
008 190717s2016 xx |||||o 00| ||eng c
024 7 |a 10.1007/s13311-016-0466-y  |2 doi 
035 |a (DE-627)1669347095 
035 |a (DE-599)KXP1669347095 
035 |a (OCoLC)1341233918 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Schwarz, Stefan  |d 1966-  |e VerfasserIn  |0 (DE-588)172656737  |0 (DE-627)697590356  |0 (DE-576)133515362  |4 aut 
245 1 0 |a Prophylactic antibiotic therapy for preventing poststroke infection  |c Stefan Schwarz 
264 1 |c 2 August 2016 
300 |a 8 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 17.07.2019 
520 |a Infections, in particular pneumonia, are common complications in patients with acute stroke and are associated with a less favorable neurologic and functional outcome. Patients with severe stroke and dysphagia are at highest risk of infection. Experimental and clinical data suggest stroke-induced immunodeficiency as a major factor contributing to the high incidence of infection after stroke. Preclinical studies support the potential benefit of preventive antibiotic therapy in acute stroke for lowering the incidence of infection and improving clinical outcome. Several smaller clinical trials on preventive antibiotic therapy in patients with stroke conducted during the last 10 years yielded inconclusive results. Recently, 2 large, open-label, controlled trials failed to demonstrate an improved clinical outcome after preventive antibiotic therapy in patients with acute stroke treated in specialized stroke units. In the “Preventive Antibiotics in Stroke Study”, antibiotic therapy lowered the rate of infection but did not influence outcome. In the STROKE-INF study, performed in patients with dysphagia after stroke, antibiotic therapy did not lower the incidence of pneumonia and had no prognostic significance. At present, preventive antibiotic therapy cannot be recommended as a therapeutic option for acute stroke. 
650 4 |a Acute stroke 
650 4 |a Antibiotic prophylaxis 
650 4 |a Fever 
650 4 |a Infection 
650 4 |a Pneumonia 
773 0 8 |i Enthalten in  |t Neurotherapeutics  |d [Amsterdam] : Elsevier B.V., 2007  |g 13(2016), 4, Seite 783-790  |h Online-Ressource  |w (DE-627)527833967  |w (DE-600)2279496-7  |w (DE-576)272351261  |x 1878-7479  |7 nnas  |a Prophylactic antibiotic therapy for preventing poststroke infection 
773 1 8 |g volume:13  |g year:2016  |g number:4  |g pages:783-790  |g extent:8  |a Prophylactic antibiotic therapy for preventing poststroke infection 
856 4 0 |u https://doi.org/10.1007/s13311-016-0466-y  |x Verlag  |x Resolving-System  |3 Volltext 
951 |a AR 
992 |a 20190717 
993 |a Article 
994 |a 2016 
998 |g 172656737  |a Schwarz, Stefan  |m 172656737:Schwarz, Stefan  |d 60000  |e 60000PS172656737  |k 0/60000/  |p 1  |x j  |y j 
999 |a KXP-PPN1669347095  |e 3494013152 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"person":[{"given":"Stefan","role":"aut","family":"Schwarz","display":"Schwarz, Stefan"}],"id":{"eki":["1669347095"],"doi":["10.1007/s13311-016-0466-y"]},"recId":"1669347095","relHost":[{"language":["eng"],"part":{"year":"2016","pages":"783-790","text":"13(2016), 4, Seite 783-790","issue":"4","volume":"13","extent":"8"},"corporate":[{"role":"isb","display":"American Society for Experimental Neurotherapeutics"}],"recId":"527833967","physDesc":[{"extent":"Online-Ressource"}],"id":{"eki":["527833967"],"issn":["1878-7479"],"zdb":["2279496-7"]},"origin":[{"publisherPlace":"[Amsterdam] ; New York, NY [u.a.] ; New York, NY","publisher":"Elsevier B.V. ; Elsevier ; Springer","dateIssuedKey":"2007","dateIssuedDisp":"2007-"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 16.05.2024"],"pubHistory":["4.2007 -"],"title":[{"title":"Neurotherapeutics","title_sort":"Neurotherapeutics","subtitle":"official journal of the American Society for Experimental NeuroTherapeutics (ASENT)"}],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Prophylactic antibiotic therapy for preventing poststroke infectionNeurotherapeutics"}],"physDesc":[{"extent":"8 S."}],"name":{"displayForm":["Stefan Schwarz"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title_sort":"Prophylactic antibiotic therapy for preventing poststroke infection","title":"Prophylactic antibiotic therapy for preventing poststroke infection"}],"note":["Gesehen am 17.07.2019"],"origin":[{"dateIssuedKey":"2016","dateIssuedDisp":"2 August 2016"}]} 
SRT |a SCHWARZSTEPROPHYLACT2201